{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:17:19Z","timestamp":1777655839354,"version":"3.51.4"},"reference-count":118,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.gtc.2021.08.005","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T01:48:13Z","timestamp":1635385693000},"page":"905-918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Scleroderma and the Esophagus"],"prefix":"10.1016","volume":"50","author":[{"given":"Nitin K.","family":"Ahuja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John O.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gtc.2021.08.005_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/RHU.0000000000000626","article-title":"Gastrointestinal involvement in systemic sclerosis: an update","volume":"24","author":"Miller","year":"2018","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.gtc.2021.08.005_bib2","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gut.2005.086074","article-title":"A\u00a0case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma)","volume":"55","author":"Roberts","year":"2006","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.gtc.2021.08.005_bib3","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/rheumatology\/keq147","article-title":"Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre","volume":"49","author":"Thoua","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.gtc.2021.08.005_bib4","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/art.1780370902","article-title":"Gastrointestinal motility disorders in scleroderma","volume":"37","author":"Sjogren","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1172\/JCI117395","article-title":"Antimyenteric neuronal antibodies in scleroderma","volume":"94","author":"Howe","year":"1994","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.gtc.2021.08.005_bib6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1053\/gast.2002.36057","article-title":"Antibody-mediated gastrointestinal dysmotility in scleroderma","volume":"123","author":"Goldblatt","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0002-9343(92)90043-B","article-title":"Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability","volume":"93","author":"Dessein","year":"1992","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/rheumatology\/kep381","article-title":"Gastrointestinal manifestation of systemic sclerosis--thickening of the upper gastrointestinal wall detected by endoscopic ultrasound is a valid sign","volume":"49","author":"Zuber-Jerger","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.gtc.2021.08.005_bib9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13075-015-0695-1","article-title":"Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures","volume":"17","author":"Taroni","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40674-017-0072-0","article-title":"The mechanistic implications of gene expression studies in SSc: insights from systems biology","volume":"3","author":"Taroni","year":"2017","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11938-008-0008-8","article-title":"Esophageal disease in progressive systemic sclerosis","volume":"11","author":"Ebert","year":"2008","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"9","key":"10.1016\/j.gtc.2021.08.005_bib12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/01.mcg.0000225549.19127.90","article-title":"Esophageal disease in scleroderma","volume":"40","author":"Ebert","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0049-0172(94)90097-3","article-title":"Gastrointestinal manifestations of systemic sclerosis","volume":"24","author":"Abu-Shakra","year":"1994","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00004836-200101000-00008","article-title":"Esophageal investigations in connective tissue disease: which tests are most appropriate?","volume":"32","author":"Ling","year":"2001","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib15","first-page":"297","article-title":"Detection of early asymptomatic esophageal dysfunction in systemic sclerosis using a new scintigraphic grading method","volume":"23","author":"Kaye","year":"1996","journal-title":"J\u00a0Rheumatol"},{"issue":"455","key":"10.1016\/j.gtc.2021.08.005_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1259\/0007-1285-38-455-825","article-title":"Progressive systemic sclerosis","volume":"38","author":"Harper","year":"1965","journal-title":"Br J Radiol"},{"issue":"7","key":"10.1016\/j.gtc.2021.08.005_bib17","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1572-0241.1998.00334.x","article-title":"Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders","volume":"93","author":"Weston","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib18","first-page":"52","article-title":"Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs","volume":"92","author":"El-Serag","year":"1997","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0016-5085(87)90137-5","article-title":"Esophagitis in scleroderma. Prevalence and risk factors","volume":"92","author":"Zamost","year":"1987","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0002-9343(87)90376-7","article-title":"Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma","volume":"82","author":"Katzka","year":"1987","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0016-5085(85)90440-8","article-title":"Systemic sclerosis (scleroderma) and esophageal adenocarcinoma: is increased patient screening necessary?","volume":"89","author":"Segel","year":"1985","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000194399","article-title":"Esophageal motility and pulmonary function in progressive systemic sclerosis","volume":"42","author":"Denis","year":"1981","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archinte.1989.00390030075014","article-title":"Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration?","volume":"149","author":"Johnson","year":"1989","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1572-0241.1998.00341.x","article-title":"Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis","volume":"93","author":"Lock","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2021.08.005_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L","article-title":"Esophageal involvement and pulmonary manifestations in systemic sclerosis","volume":"45","author":"Marie","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02988598","article-title":"Esophageal hypomotility in systemic sclerosis: close relationship with pulmonary involvement","volume":"15","author":"Kinuya","year":"2001","journal-title":"Ann Nucl Med"},{"issue":"5","key":"10.1016\/j.gtc.2021.08.005_bib27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1164\/rccm.200808-1359OC","article-title":"Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring","volume":"179","author":"Savarino","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.gtc.2021.08.005_bib28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3899\/jrheum.120705","article-title":"Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis","volume":"40","author":"Zhang","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7326\/0003-4819-121-1-199407010-00002","article-title":"Pulmonary function and gastroesophageal reflux in systemic sclerosis","volume":"121","author":"Troshinsky","year":"1994","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.semarthrit.2010.03.002","article-title":"Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence","volume":"40","author":"Christmann","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.gtc.2021.08.005_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/BF01333709","article-title":"Esophageal motility in progressive systemic sclerosis (PSS). Comparison of cine-radiographic and manometric evaluation","volume":"24","author":"Clements","year":"1979","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.gtc.2021.08.005_bib32","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.crad.2008.05.007","article-title":"The role of radiology in the management of systemic sclerosis","volume":"63","author":"Madani","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1016\/j.gtc.2021.08.005_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12876-015-0241-2","article-title":"Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study","volume":"15","author":"Arif","year":"2015","journal-title":"BMC Gastroenterol"},{"issue":"11\u201312","key":"10.1016\/j.gtc.2021.08.005_bib34","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1365-2036.2006.03180.x","article-title":"Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy","volume":"24","author":"Marie","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.gtc.2021.08.005_bib35","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/art.1780401222","article-title":"Esophageal dysfunction in scleroderma: relationship with disease subsets","volume":"40","author":"Bassotti","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00296-010-1595-y","article-title":"Early endoscopy in systemic sclerosis without gastrointestinal symptoms","volume":"32","author":"Thonhofer","year":"2012","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s002960050010","article-title":"Esophageal manometry in systemic sclerosis: screening procedure or confined to symptomatic patients?","volume":"17","author":"Lock","year":"1997","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.gtc.2021.08.005_bib38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/rheumatology\/kes429","article-title":"Gastrointestinal motility disorder assessment in systemic sclerosis","volume":"52","author":"Savarino","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.gtc.2021.08.005_bib39","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.cgh.2016.03.039","article-title":"Loss of peristaltic reserve, determined by multiple rapid swallows, is the most frequent esophageal motility abnormality in patients with systemic sclerosis","volume":"14","author":"Carlson","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.gtc.2021.08.005_bib40","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/nmo.12813","article-title":"The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters","volume":"28","author":"Kimmel","year":"2016","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib41","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11926-014-0475-y","article-title":"Advances in the evaluation and management of esophageal disease of systemic sclerosis","volume":"17","author":"Carlson","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"10.1016\/j.gtc.2021.08.005_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13073","article-title":"Esophagogastric junction in systemic sclerosis: a study with the functional lumen imaging probe","volume":"29","author":"Fynne","year":"2017","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2982.2006.00837.x","article-title":"A\u00a0new method for evaluation of intestinal muscle contraction properties: studies in normal subjects and in patients with systemic sclerosis","volume":"19","author":"Gregersen","year":"2007","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13247","article-title":"Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients","volume":"30","author":"Stern","year":"2018","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"10.1016\/j.gtc.2021.08.005_bib45","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","article-title":"EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)","volume":"68","author":"Kowal-Bielecka","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6 Suppl 86","key":"10.1016\/j.gtc.2021.08.005_bib46","article-title":"Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis","volume":"32","author":"Hansi","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.gtc.2021.08.005_bib47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/rheumatology\/28.6.553","article-title":"Treatment of oesophagitis in scleroderma with omeprazole","volume":"28","author":"Olive","year":"1989","journal-title":"Br J Rheumatol"},{"issue":"5","key":"10.1016\/j.gtc.2021.08.005_bib48","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2036.1991.tb00516.x","article-title":"Hydroxyproline in the oesophageal mucosa of patients with progressive systemic sclerosis during omeprazole-induced healing of reflux oesophagitis","volume":"5","author":"Hendel","year":"1991","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.gtc.2021.08.005_bib49","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3109\/00365528609011120","article-title":"Long-term ranitidine in progressive systemic sclerosis (scleroderma) with gastroesophageal reflux","volume":"21","author":"Hendel","year":"1986","journal-title":"Scand J Gastroenterol"},{"issue":"4 Pt 1","key":"10.1016\/j.gtc.2021.08.005_bib50","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0016-5085(79)90223-3","article-title":"Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study","volume":"77","author":"Petrokubi","year":"1979","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.gtc.2021.08.005_bib51","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1365-2036.2007.03469.x","article-title":"Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial","volume":"26","author":"Janiak","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/rheumatology\/kew216","article-title":"Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial","volume":"56","author":"Foocharoen","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0016-5085(87)91020-1","article-title":"Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis","volume":"93","author":"Horowitz","year":"1987","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.gtc.2021.08.005_bib54","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/BF01660958","article-title":"[Effect of cisapride on esophageal motility in healthy probands and patients with progressive systemic scleroderma]","volume":"68","author":"Wehrmann","year":"1990","journal-title":"Klin Wochenschr"},{"issue":"6","key":"10.1016\/j.gtc.2021.08.005_bib55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2125.1991.tb05593.x","article-title":"The effect of cisapride on gastro-oesophageal dysfunction in systemic sclerosis: a controlled manometric study","volume":"31","author":"Kahan","year":"1991","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s100670200010","article-title":"Effects of cisapride on oesophageal transit of solids in patients with progressive systemic sclerosis","volume":"21","author":"Wang","year":"2002","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.gtc.2021.08.005_bib57","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archinte.1987.00370090075014","article-title":"Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities","volume":"147","author":"Johnson","year":"1987","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.gtc.2021.08.005_bib58","first-page":"685","article-title":"Metoclopramide response in patients with early diffuse systemic sclerosis. Effects on esophageal motility abnormalities","volume":"23","author":"Mercado","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.gtc.2021.08.005_bib59","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/00365529409092515","article-title":"Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients","volume":"29","author":"Fiorucci","year":"1994","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semarthrit.2017.12.007","article-title":"Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis","volume":"48","author":"Ahuja","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13075-017-1340-y","article-title":"Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study","volume":"19","author":"Vigone","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.gtc.2021.08.005_bib62","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cgh.2012.06.036","article-title":"Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia","volume":"10","author":"Tack","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2021.08.005_bib63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13075-016-1094-y","article-title":"The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial","volume":"18","author":"Karamanolis","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib64","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/2050640614560453","article-title":"Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: a pilot study","volume":"3","author":"Karamanolis","year":"2015","journal-title":"United European Gastroenterol J"},{"issue":"5","key":"10.1016\/j.gtc.2021.08.005_bib65","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0022-5223(19)40561-8","article-title":"Surgical management of esophageal scleroderma","volume":"66","author":"Henderson","year":"1973","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.gtc.2021.08.005_bib66","first-page":"624","article-title":"Combined Collis gastroplasty--fundoplication operations for scleroderma reflux esophagitis","volume":"90","author":"Orringer","year":"1981","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib67","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0003-4975(95)00164-6","article-title":"1988: surgery for scleroderma of the esophagus: a 12-year experience. Updated in 1995","volume":"60","author":"Mansour","year":"1995","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0003-4975(94)91073-1","article-title":"Antireflux operations in patients with scleroderma","volume":"58","author":"Poirier","year":"1994","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.gtc.2021.08.005_bib69","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.athoracsur.2007.06.025","article-title":"Comparison of surgical approaches to recalcitrant gastroesophageal reflux disease in the patient with scleroderma","volume":"84","author":"Kent","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib70","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0049-0172(80)90013-X","article-title":"Mixed connective tisssue disease: a clinicopathologic study of 20 cases","volume":"10","author":"Bennett","year":"1980","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib72","first-page":"141","article-title":"Esophageal disorders in mixed connective tissue diseases","volume":"9","author":"Nica","year":"2016","journal-title":"J\u00a0Med Life"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib73","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/art.1780230312","article-title":"Undifferentiated connective tissue syndromes","volume":"23","author":"LeRoy","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.gtc.2021.08.005_bib74","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.rmed.2008.12.018","article-title":"Esophageal involvement and interstitial lung disease in mixed connective tissue disease","volume":"103","author":"Fagundes","year":"2009","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.gtc.2021.08.005_bib75","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.prp.2011.04.002","article-title":"Histological analysis of esophageal muscular layers from 27 autopsy cases with mixed connective tissue disease (MCTD)","volume":"207","author":"Uzuki","year":"2011","journal-title":"Pathol Res Pract"},{"issue":"6","key":"10.1016\/j.gtc.2021.08.005_bib76","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00002281-199511000-00017","article-title":"Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions","volume":"7","author":"Kallenberg","year":"1995","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.gtc.2021.08.005_bib77","first-page":"685","article-title":"Esophageal involvement in mixed connective tissue disease","volume":"18","author":"Doria","year":"1991","journal-title":"J\u00a0Rheumatol"},{"issue":"5 Pt 1","key":"10.1016\/j.gtc.2021.08.005_bib78","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0016-5085(12)90338-8","article-title":"Gastrointestinal manifestations of mixed connective tissue disease","volume":"98","author":"Marshall","year":"1990","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib79","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2036.2009.04190.x","article-title":"Review article: the gastrointestinal complications of myositis","volume":"31","author":"Ebert","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1148\/89.1.27","article-title":"The esophageal lesions in dermatomyositis. A correlation of radiologic and pathologic findings","volume":"89","author":"O'Hara","year":"1967","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.gtc.2021.08.005_bib81","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/art.1780230412","article-title":"Cricopharyngeal muscle dysfunction in the differential diagnosis of dysphagia in polymyositis","volume":"23","author":"Dietz","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.gtc.2021.08.005_bib82","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/archinte.1983.00350120052013","article-title":"The esophageal motility disorder of polymyositis. A prospective study","volume":"143","author":"Jacob","year":"1983","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.gtc.2021.08.005_bib83","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/art.1780260804","article-title":"Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis","volume":"26","author":"de Merieux","year":"1983","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.gtc.2021.08.005_bib84","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780280606","article-title":"Cricopharyngeal obstruction in inflammatory myopathy (polymyositis\/dermatomyositis). Report of three cases and review of the literature","volume":"28","author":"Kagen","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.gtc.2021.08.005_bib85","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PHM.0000000000001354","article-title":"Dysphagia in myositis: a study of the structural and physiologic changes resulting in disordered swallowing","volume":"99","author":"Azola","year":"2020","journal-title":"Am J Phys Med Rehabil"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib86","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mus.25507","article-title":"High-resolution manometry in patients with idiopathic inflammatory myopathy: elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset","volume":"56","author":"Casal-Dominguez","year":"2017","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.gtc.2021.08.005_bib87","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4253\/wjge.v9.i4.183","article-title":"Endoscopic balloon catheter dilatation","volume":"9","author":"Chandrasekhara","year":"2017","journal-title":"World J Gastrointest Endosc"},{"key":"10.1016\/j.gtc.2021.08.005_bib88","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jns.2017.07.031","article-title":"Botulinum toxin alleviates dysphagia of patients with inclusion body myositis","volume":"380","author":"Schrey","year":"2017","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.gtc.2021.08.005_bib89","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008058","article-title":"Cricopharyngeal myotomy for cricopharyngeus stricture in an inclusion body myositis patient with hiatus hernia: a learning experience","volume":"2013","author":"Sanei-Moghaddam","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib90","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MCG.0b013e3182329d9c","article-title":"Gastrointestinal and hepatic manifestations of Sjogren syndrome","volume":"46","author":"Ebert","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib91","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.rdc.2017.09.010","article-title":"Gastrointestinal and hepatic disease in Sjogren syndrome","volume":"44","author":"Popov","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.gtc.2021.08.005_bib92","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/BF02087419","article-title":"Esophageal motility disorders in patients with Sj\u00f6gren's syndrome","volume":"39","author":"Palma","year":"1994","journal-title":"Dig Dis Sci"},{"issue":"13","key":"10.1016\/j.gtc.2021.08.005_bib93","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1523\/JNEUROSCI.16-13-04155.1996","article-title":"Multiple subtypes of voltage-gated calcium channel mediate transmitter release from parasympathetic neurons in the mouse bladder","volume":"16","author":"Waterman","year":"1996","journal-title":"J\u00a0Neurosci"},{"issue":"5","key":"10.1016\/j.gtc.2021.08.005_bib94","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/art.39044","article-title":"Predominant glandular cholinergic dysautonomia in patients with primary Sj\u00f6gren's syndrome","volume":"67","author":"Imrich","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib95","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01318111","article-title":"Esophageal function, radiography, and dysphagia in Sj\u00f6gren's syndrome","volume":"31","author":"Kjell\u00e9n","year":"1986","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib96","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00455-015-9657-7","article-title":"Swallowing disorders in Sj\u00f6gren's syndrome: prevalence, risk factors, and effects on quality of life","volume":"31","author":"Pierce","year":"2016","journal-title":"Dysphagia"},{"issue":"5","key":"10.1016\/j.gtc.2021.08.005_bib97","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1191\/0961203302lu195cr","article-title":"Dysphagia in a patient with lupus and review of the literature","volume":"11","author":"Chua","year":"2002","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.gtc.2021.08.005_bib98","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MCG.0b013e31820f81b8","article-title":"Gastrointestinal and hepatic manifestations of systemic lupus erythematosus","volume":"45","author":"Ebert","year":"2011","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"17","key":"10.1016\/j.gtc.2021.08.005_bib99","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1001\/jama.1979.03300170041026","article-title":"Esophageal motor dysfunction in systemic lupus erythematosus. Two cases with unusual features","volume":"242","author":"Peppercorn","year":"1979","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0049-0172(90)90057-M","article-title":"Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus","volume":"20","author":"ter Borg","year":"1990","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib101","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MCG.0000000000000989","article-title":"Clinical characteristics and associated systemic diseases in patients with esophageal \"absent contractility\"-a clinical algorithm","volume":"53","author":"Laique","year":"2019","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"7","key":"10.1016\/j.gtc.2021.08.005_bib102","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/BF01297214","article-title":"Esophageal dysfunction in patients with mixed connective tissue diseases and systemic lupus erythematosus","volume":"27","author":"Gutierrez","year":"1982","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib103","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF01072623","article-title":"Esophageal motility in systemic lupus erythematosus","volume":"19","author":"Ramirez-Mata","year":"1974","journal-title":"Am J Dig Dis"},{"issue":"15","key":"10.1016\/j.gtc.2021.08.005_bib104","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/03009740310002461","article-title":"Muscle metabolism in fibromyalgia studied by P-31 magnetic resonance spectroscopy during aerobic and anaerobic exercise","volume":"32","author":"Lund","year":"2003","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.gtc.2021.08.005_bib106","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01300088","article-title":"Bowel dysfunction in fibromyalgia syndrome","volume":"36","author":"Triadafilopoulos","year":"1991","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.gtc.2021.08.005_bib107","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11916-996-0009-z","article-title":"Fibromyalgia: the gastrointestinal link","volume":"8","author":"Wallace","year":"2004","journal-title":"Curr Pain Headache Rep"},{"issue":"10","key":"10.1016\/j.gtc.2021.08.005_bib108","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/j.pain.0000000000000994","article-title":"Bidirectional association between fibromyalgia and gastroesophageal reflux disease: two population-based retrospective cohort analysis","volume":"158","author":"Wang","year":"2017","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.gtc.2021.08.005_bib109","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.mcna.2010.01.002","article-title":"Noncardiac chest pain and fibromyalgia","volume":"94","author":"Almansa","year":"2010","journal-title":"Med Clin North Am"},{"issue":"10","key":"10.1016\/j.gtc.2021.08.005_bib110","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41395-018-0215-4","article-title":"Postural tachycardia syndrome (POTS) and the GI tract: a primer for the gastroenterologist","volume":"113","author":"DiBaise","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gtc.2021.08.005_bib111","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13013","article-title":"Gastrointestinal disorders in joint hypermobility syndrome\/Ehlers-Danlos syndrome hypermobility type: a review for the gastroenterologist","volume":"29","author":"Beckers","year":"2017","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"10.1016\/j.gtc.2021.08.005_bib112","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.amjms.2018.03.001","article-title":"Spectrum of gastrointestinal manifestations in joint hypermobility syndromes","volume":"355","author":"Botrus","year":"2018","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.gtc.2021.08.005_bib113","article-title":"Rome IV functional gastrointestinal disorders and health impairment in subjects with hypermobility spectrum disorders or hypermobile Ehlers-Danlos syndrome","author":"Lam","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.gtc.2021.08.005_bib114","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.cgh.2014.01.014","article-title":"A\u00a0prospective evaluation of undiagnosed joint hypermobility syndrome in patients with gastrointestinal symptoms","volume":"12","author":"Fikree","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gtc.2021.08.005_bib115","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ajmg.a.33231","article-title":"Natural history and manifestations of the hypermobility type Ehlers-Danlos syndrome: a pilot study on 21 patients","volume":"152A","author":"Castori","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"11","key":"10.1016\/j.gtc.2021.08.005_bib116","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/nmo.12665","article-title":"Ehlers Danlos syndrome and gastrointestinal manifestations: a 20-year experience at Mayo Clinic","volume":"27","author":"Nelson","year":"2015","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"10.1016\/j.gtc.2021.08.005_bib117","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13029","article-title":"Mechanisms underlying reflux symptoms and dysphagia in patients with joint hypermobility syndrome, with and without postural tachycardia syndrome","volume":"29","author":"Fikree","year":"2017","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"10.1016\/j.gtc.2021.08.005_bib118","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000345998","article-title":"Surgical recommendations in Ehlers-Danlos syndrome(s) need patient classification: the example of Ehlers-Danlos syndrome hypermobility type (a.k.a. joint hypermobility syndrome)---reply","volume":"29","author":"Burcharth","year":"2012","journal-title":"Dig Surg"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855321007093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855321007093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:32:03Z","timestamp":1760178723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855321007093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":118,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0889855321007093"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2021.08.005","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scleroderma and the Esophagus","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2021.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}